Clinical Trials Browser

Phase 2 × Completed × Metastatic Castration-resistant Prostate Cancer × Clear all

NCT04158245 2025-09-22

18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies

Phase 2 Completed

9 enrolled 14 charts

Metastatic Castration-resistant Prostate Cancer

NCT04676607 2023-06-13

SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Completed

Metastatic Castration-resistant Prostate Cancer